Given the tremendous business opportunity that the African pharmaceutical market represents, countries like India and China have anticipated the trend and developed strategies for doing business in Africa. India and China pharmaceutical companies have been working with local government and NGOs to commercialize several generic drugs for the past 10 years. India pharmaceutical exports to Africa went from 8.4% in 2002 to 17.7% in 2011 and
15% of India $1 Billion pharmaceutical export went to Kenya, Uganda, and Nigeria only. China’s pharmaceutical export to Africa went from 2.0% in 2002 to 4.1% in 2011. Where have American pharmaceutical companies been?
INDIA AND CHINA ARE LEADING THE WAY...
According to the Office of the United States Trade Representative, the total U.S. export to sub-Saharan Africa was $21.1 billion in 2011, up 23% compared to 2010. U.S. top export categories were Machinery ($4.0 billion; up 15%), Vehicles and Parts ($3.5 billion; up 42%), Non-Crude Oil ($1.8 billion; up 30%); cereals ($1.7 billion; up 31%); and Aircraft and Parts ($1.5 billion; up 32%). Sadly, out-off 1552 pharmaceutical companies registered in the U.S. only few manufacturers do business with Africa. This originate from the fact that U.S. companies have little to no knowledge at all about the African market and the dynamics of doing business in Africa.
Afeli Pharmaceuticals, a company founded by a young and dynamic African with a PhD degree in pharmaceutical sciences from the University of South Carolina, can help you establish and develop a market for your pharmaceutical products or medical equipment in Africa by providing export solutions unique to your company.
AMERICAN PHARMACEUTICAL COMPANIES ARE MISSING THE OPPORTUNITY- HOPEFULLY NOT FOR MUCH LONGER
According to IMS Health, it is projected that by 2016, the African pharmaceutical market will reach $30 billion and by 2020, this number could approximate $45 billion due to the rise in a middle class and to the fact that more countries are becoming democratic. There will be an increasing need for medical equipment and drugs used in the treatment of chronic and life threatening diseases including but not limited to asthma, COPD, diabetes, cancer, HIV-AIDS, malaria, stroke, hypertension, and cardiovascular diseases.
A PROMISING PHARMACEUTICAL MARKET
Africa is the second most populated continent in the world just behind Asia with a population of about 1.1 billion people. It is estimated that by year 2030, Africa's total population could reach 1.6 billion people. Africa is a very diverse continent with 54 countries including 21 french-speaking countries, 24 English-speaking countries, 7 Arabic countries, and 2 Portuguese-speaking countries. The most populated countries include:
AFELI Pharmaceuticals © ALL RIGHTS RESERVED.